Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Journal of Medical Virology|July 10, 2026
Surveillance of CMV Terminase Gene Mutations in Allogeneic Hematopoietic Stem Cell Transplant Recipients Receiving Letermovir ProphylaxisAmandine Caillault, Alienor Xhaard, Severine Mercier-Delarue, et al.
Blood|September 14, 2013
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethalityAsim Saha, Kazutoshi Aoyama, Patricia A Taylor, et al.
Leukemia Research|January 16, 2017
Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFALining Wang, Emmanuel Raffoux, Xavier Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2023
Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE StudyDavid Bernard Miklos, Mohammad Abu Zaid, Julian P Cooney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2015
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortalityMargaret L MacMillan, Marie Robin, Andrew C Harris, et al.
Blood Advances|May 26, 2018
Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?Tara M Robinson, Ephraim J Fuchs, Mei-Jie Zhang, et al.
Haematologica|March 23, 2023
Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experienceGerard Socie, Jacques-Emmanuel Galimard, Emmanuel Raffoux, et al.
Transplantation and Cellular Therapy|April 20, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group ReportKirsten M Williams, Yoshihiro Inamoto, Annie Im, et al.
Haematologica|March 23, 2023
Graft-<i>versus</i>-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMTRaynier Devillier, Dirk-Jan Eikema, Carlo Dufour, et al.
Bone Marrow Transplantation|June 4, 2024
Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working partyJean El Cheikh, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Pageof 8